Home

SINT

(SINT)

NCM – Real Time Price. Currency in USD

2.28

-0.14 (-5.79%)

At close: Mar 27, 2026, 4:00 PM EDT

2.39

+0.11 (4.63%)

After-hours: Mar 27, 2026, 5:37 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Get all premium features to the best stock analysis tool

Finranks

Company

About us

Contact us

[email protected]

Instagram
Telegram
LinkedIn

Home
Markets
Screener
News
About

SINT - Sintx Technologies, Inc. Latest News | Finranks

Home

SINT

(SINT)

NCM – Real Time Price. Currency in USD

2.28

-0.14 (-5.79%)

At close: Mar 27, 2026, 4:00 PM EDT

2.39

+0.11 (4.63%)

After-hours: Mar 27, 2026, 5:37 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Videos

No Data

There is no data to display

Press releases

23.03.2026

SINTX Technologies Provides Corporate Business Update Highlighting First Human Implant, Strategic Transformation, and Commercial Execution

Clinical milestone, new President appointment, and platform expansion position SINTX for commercial rollout and revenue growth in 2026

19.03.2026

SINTX Technologies Announces First-In-Human Surgery Using FDA-Cleared SINAPTIC® Foot & Ankle Implant

Major clinical milestone marks SINTX's entry into the foot and ankle reconstruction market and advances commercialization of its silicon nitride biomaterial platform

18.02.2026

SINTX Technologies Appoints Ryan Elmore President to Lead Channel Expansion of Silicon Nitride Biomaterial Platforms

Appointment supports acceleration of revenue opportunities from SiNERGY ™ silicon nitride devices and antipathogenic fibrous material technologies

29.01.2026

SINTX Technologies to Participate in Noble Capital Markets' Emerging Growth Virtual Equity Conference on February 4–5

SALT LAKE CITY, Utah, Jan. 29, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an advanced ceramics and biomaterials company focused on silicon-nitride-based medical technologies, today announced that its management team will present at the Noble Capital Markets Emerging Growth Virtual Equity Conference, to be held February 4–5, 2026.

(SINT)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

(SINT)

Videos

No Data

Press releases

SINTX Technologies Provides Corporate Business Update Highlighting First Human Implant, Strategic Transformation, and Commercial Execution

SINTX Technologies Announces First-In-Human Surgery Using FDA-Cleared SINAPTIC® Foot & Ankle Implant

SINTX Technologies Appoints Ryan Elmore President to Lead Channel Expansion of Silicon Nitride Biomaterial Platforms

SINTX Technologies to Participate in Noble Capital Markets' Emerging Growth Virtual Equity Conference on February 4–5